Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer

Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer

Abstract Background Fibroblast activation protein (FAP) is expressed in the tumor microenvironment (TME) of various cancers. In our analysis, we describe the impact of dual-tracer imaging with Gallium-68-radiolabeled inhibitors of FAP (FAPI-46-PET/CT) and fluorodeoxy-D-glucose (FDG-PET/CT) on the ra...

Полное описание

Библиографические подробности
Главные авторы: Simone Wegen, Karina Claus, Philipp Linde, Johannes Rosenbrock, Maike Trommer, Thomas Zander, Armin Tuchscherer, Christiane Bruns, Hans Anton Schlößer, Wolfgang Schröder, Marie-Lisa Eich, Thomas Fischer, Klaus Schomäcker, Alexander Drzezga, Carsten Kobe, Katrin Sabine Roth, Jasmin Josefine Weindler
Формат: Статья
Язык:English
Опубликовано: BMC 2024-04-01
Серии:Radiation Oncology
Предметы:
FDG
Esophageal cancer
FAPI-46
Radiotherapy planning
PET-based
Online-ссылка:https://doi.org/10.1186/s13014-024-02430-9

Internet

https://doi.org/10.1186/s13014-024-02430-9

Схожие документы